These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1634141)

  • 21. Papillary serous adenocarcinoma of the endometrium.
    Jeffrey JF; Krepart GV; Lotocki RJ
    Obstet Gynecol; 1986 May; 67(5):670-4. PubMed ID: 3960439
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Positive peritoneal cytology is an adverse factor in endometrial carcinoma only if there is other evidence of extrauterine disease.
    Kadar N; Homesley HD; Malfetano JH
    Gynecol Oncol; 1992 Aug; 46(2):145-9. PubMed ID: 1500014
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Uterine papillary serous carcinoma: a highly malignant form of endometrial adenocarcinoma.
    Hendrickson M; Ross J; Eifel P; Martinez A; Kempson R
    Am J Surg Pathol; 1982 Mar; 6(2):93-108. PubMed ID: 7102898
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of unfavorable histologic subtypes in endometrial adenocarcinoma.
    Wilson TO; Podratz KC; Gaffey TA; Malkasian GD; O'Brien PC; Naessens JM
    Am J Obstet Gynecol; 1990 Feb; 162(2):418-23; discussion 423-6. PubMed ID: 2309824
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Extrauterine spread in endometrial carcinoma clinically confined to the uterus.
    Chen SS
    Gynecol Oncol; 1985 May; 21(1):23-31. PubMed ID: 3988126
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Uterine serous carcinoma. A morphologically diverse neoplasm with unifying clinicopathologic features.
    Sherman ME; Bitterman P; Rosenshein NB; Delgado G; Kurman RJ
    Am J Surg Pathol; 1992 Jun; 16(6):600-10. PubMed ID: 1599038
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Role of Adjuvant Therapy for Stage IA Serous and Clear Cell Uterine Cancer: Is Observation a Valid Strategy?
    Velker V; D'Souza D; Prefontaine M; McGee J; Leung E
    Int J Gynecol Cancer; 2016 Mar; 26(3):491-6. PubMed ID: 26825823
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Uterine papillary serous carcinoma: a review.
    Dunton CJ; Balsara G; McFarland M; Hernandez E
    Obstet Gynecol Surv; 1991 Feb; 46(2):97-102. PubMed ID: 1997927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Analysis of treatment failures and survival of patients with uterine papillary serous carcinoma: a Cooperation Task Force (CTF) Study.
    Gadducci A; Cosio S; Landoni F; Maggino T; Zola P; Fuso L; Sartori E
    Int J Gynecol Cancer; 2012 Oct; 22(8):1355-60. PubMed ID: 22976496
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Uterine papillary serous carcinoma--one kind of special type of uterine endometrial carcinoma].
    Wu M; Lang J; Guo L
    Zhonghua Fu Chan Ke Za Zhi; 1996 Jan; 31(1):3-7. PubMed ID: 8758809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endometrioid carcinoma simultaneously involving the uterus and the fallopian tube: a clinicopathologic study of 13 cases.
    Culton LK; Deavers MT; Silva EG; Liu J; Malpica A
    Am J Surg Pathol; 2006 Jul; 30(7):844-9. PubMed ID: 16819326
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of clinical and pathological characteristics, treatment methods, survival, and prognosis of uterine papillary serous carcinoma.
    Solmaz U; Ekin A; Mat E; Gezer C; Dogan A; Biler A; Peker N; Hasdemir PS; Sanci M
    Tumori; 2016 Dec; 102(6):593-599. PubMed ID: 27514313
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Uterine papillary serous, clear cell, and poorly differentiated endometrioid carcinomas: a comparative study.
    Greggi S; Mangili G; Scaffa C; Scala F; Losito S; Iodice F; Pisano C; Montoli S; Viganò R; Pirozzi G; Giannarelli D
    Int J Gynecol Cancer; 2011 May; 21(4):661-7. PubMed ID: 21412164
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Extended surgical staging for uterine papillary serous carcinoma: survival outcome of locoregional (Stage I-III) disease.
    Bristow RE; Asrari F; Trimble EL; Montz FJ
    Gynecol Oncol; 2001 May; 81(2):279-86. PubMed ID: 11330963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long-term survival in uterine clear cell carcinoma and uterine papillary serous carcinoma.
    Lindahl B; Persson J; Ranstam J; Willén R
    Anticancer Res; 2010 Sep; 30(9):3727-30. PubMed ID: 20944161
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A clinicopathologic study of endometrial carcinoma with special reference to new histological variants.
    Sato Y; Ozaki M; Ueda G; Tanizawa O
    Nihon Sanka Fujinka Gakkai Zasshi; 1985 Jun; 37(6):1015-9. PubMed ID: 2991395
    [TBL] [Abstract][Full Text] [Related]  

  • 37. DNA content as a prognostic factor in endometrial carcinoma.
    Newbury R; Schuerch C; Goodspeed N; Fanning J; Glidewell O; Evans M
    Obstet Gynecol; 1990 Aug; 76(2):251-7. PubMed ID: 2371030
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Optimal cytoreduction, depth of myometrial invasion, and age are independent prognostic factors for survival in women with uterine papillary serous and clear cell carcinomas.
    Solmaz U; Mat E; Ekin A; Gezer C; Biler A; Peker N; Ayaz D; Sanci M
    Int J Surg; 2016 Aug; 32():71-7. PubMed ID: 27365052
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Metastatic uterine serous carcinoma originating in an endometrial polyp: a report of 2 cases.
    Childs AJ; Burke JJ; Perry MY; Gallup DG
    J Reprod Med; 2005 Mar; 50(3):209-12. PubMed ID: 15841935
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Malignant Endometrial Polyps in Uterine Serous Carcinoma: The Prognostic Value of Polyp Size and Lymphovascular Invasion.
    Ouyang C; Frimer M; Hou LY; Wang Y; Goldberg GL; Hou JY
    Int J Gynecol Cancer; 2018 Mar; 28(3):524-528. PubMed ID: 29420362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.